Showing results (531-540 of 2,688) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|June 8, 2020
Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort studyJeffrey R Strich, Sarah Warner, Yi Ling Lai, et al.
The Lancet. Infectious Diseases|June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative studyYang Wang, Chunyan Xu, Rong Zhang, et al.
The Lancet. Infectious Diseases|August 7, 2021
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysisKieran Rustage, Jessica Lobe, Sally E Hayward, et al.
The Lancet. Infectious Diseases|September 10, 2021
The importance of understanding the infectious microenvironmentThomas Bjarnsholt, Marvin Whiteley, Kendra P Rumbaugh, et al.
The Lancet. Infectious Diseases|September 9, 2021
Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort studyChristine S Ho, Pei-Jean I Feng, Masahiro Narita, et al.
The Lancet. Infectious Diseases|August 30, 2021
Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature reviewGregory L Damhorst, Abigail Watts, Alfonso Hernandez-Romieu, et al.
The Lancet. Infectious Diseases|January 28, 2023
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trialKirsten E Lyke, Andrea A Berry, Kaitlin Mason, et al.
The Lancet. Infectious Diseases|January 30, 2023
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trialJustin Z Chen, Holly L Hoang, Maryna Yaskina, et al.
The Lancet. Infectious Diseases|March 9, 2023
Prevention of non-ventilator-associated hospital-acquired pneumonia in Switzerland: a type 2 hybrid effectiveness-implementation trialAline Wolfensberger, Lauren Clack, Stefanie von Felten, et al.
The Lancet. Infectious Diseases|November 14, 2022
Understanding clinical outcome measures reported in HIV pregnancy studies involving antiretroviral-naive and antiretroviral-experienced womenAhizechukwu C Eke, Rahel D Gebreyohannes, Anna M Powell
Pageof 269